These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 13270232)

  • 1. Serum glutamic-oxalacetic-transaminase activity as an index of liver-cell injury from cancer; a preliminary report.
    WROBLEWSKI F; LADUE JS
    Cancer; 1955; 8(6):1155-63. PubMed ID: 13270232
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: a preliminary report.
    WROBLEWSKI F; LADUE JS
    Ann Intern Med; 1955 Aug; 43(2):345-60. PubMed ID: 13239030
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity.
    MOLANDER DW; WROBLEWSKI F; LADUE JS
    J Lab Clin Med; 1955 Dec; 46(6):831-9. PubMed ID: 13271882
    [No Abstract]   [Full Text] [Related]  

  • 4. [SIGNIFICANT BEHAVIOR AND VALUE OF SOME ENZYMATIC ACTIVITIES OF THE BLOOD FOR DIAGNOSIS OF HEPATIC METASTASES. (II GLUTAMIC-OXALACETIC AND GLUTAMIC-PYRUVIC TRANSAMINASES)].
    GATTA L; DANIELI GG
    Riv Gastroenterol; 1964; 16():254-63. PubMed ID: 14312184
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease].
    BOSTANCI N; BIYAL F
    Turk Tip Cemiy Mecm; 1959 Sep; 25():444-54. PubMed ID: 13803091
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of liver damage on serum glutamic oxalacetic transaminase and glutamic pyruvic transaminase.
    RANGAM CM; SHRIVASTAVA KK; GUPTA JC
    J Indian Med Assoc; 1962 Apr; 38():395-9. PubMed ID: 14490264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of serum glutamic oxalacetic transaminase in the diagnosis of liver metastases].
    BADEN H; ENGBERG H; IVERSEN K; JAGT T
    Nord Med; 1960 Feb; 63():211-4. PubMed ID: 13795642
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in serum glutamic oxalacetic transaminase in patients with diseases of the heart, liver or musculoskeletal systems.
    MOORE CB; BIRCHALL R; HORACK HM; BATSON HM
    Am J Med Sci; 1957 Nov; 234(5):528-37. PubMed ID: 13487565
    [No Abstract]   [Full Text] [Related]  

  • 9. Value of serum glutamic oxalacetic transaminase in detecting subclinical liver metastases.
    BADEN H; ENGBERG H; IVERSEN K; JAGT T
    Arch Surg; 1960 Oct; 81():608-10. PubMed ID: 13685741
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum glutamic oxalacetic transaminase. Specificity of values in hepatocellular injury.
    WIRTSCHAFTER ZT; TSUJIMURA JK
    Arch Environ Health; 1961 Jan; 2():16-22. PubMed ID: 13785982
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum glutamic oxalacetic transaminase in diseases of the liver and biliary tract.
    MADSEN S; BANG NU; IVERSEN K
    Br Med J; 1958 Mar; 1(5070):543-6. PubMed ID: 13510721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glutamic-oxalacetic and glutamic-pyruvic transaminases in the blood in acute heart and liver diseases in the aged].
    OLLENDORFF P
    Ugeskr Laeger; 1960 Mar; 122():438-40. PubMed ID: 14428753
    [No Abstract]   [Full Text] [Related]  

  • 13. [The behavior of serum glutamic acid-oxalacetic acid transaminase in myopathies and neurogenic muscle atrophies].
    KAESER HE
    Dtsch Z Nervenheilkd; 1959; 179():353-62. PubMed ID: 14408360
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for increased serum glutamic oxalacetic transaminase (SGO-T) activity following graded myocardial infarcts in dogs.
    NYDICK I; WROBLEWSKI F; LADUE JS
    Circulation; 1955 Aug; 12(2):161-8. PubMed ID: 13240795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum glutamic-oxalacetic transaminase activity and its clinical significance in diseases of the heart, liver, brain, muscle and in other disease].
    CHIANG SC; HSIAO ST; WANG C
    Zhonghua Nei Ke Za Zhi; 1958 Sep; 6(9):869-72; English abstract 101. PubMed ID: 13608726
    [No Abstract]   [Full Text] [Related]  

  • 16. [NEW DIAGNOSTIC POSSIBILITIES IN DISEASES OF THE LIVER INCLUDING CANCER].
    NEUMAYR A
    Wien Med Wochenschr; 1964 Mar; 114():157-62. PubMed ID: 14166128
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical value of the determination of serum guanase activity. Studies on patients and experimental data from mongrel dogs and cultured rat hepatocytes.
    Ito S; Takaoka T; Nakaya Y; Hiasa Y; Mori H; Tanaka K; Ichihara A
    Gastroenterology; 1982 Nov; 83(5):1102-8. PubMed ID: 6288507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Critical analysis of the blood glutamic oxalacetic and glutamic pyruvic transaminases in hepatology (Apropos of 100 paired determinations accomplished during the observation of 50 patients)].
    MORETTI G; STAEFFEN J; BALLAN P; DEMANGE G
    J Med Bord; 1959 Sep; 136():1043-8. PubMed ID: 14424078
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevations of serum glutamic-oxalacetic transaminase and urinary coproporphyrins in pseudohypertrophic muscular dystrophy.
    RITTER JA; SELIGSON D
    Am J Med Sci; 1957 May; 233(5):559-62. PubMed ID: 13410932
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differences in serum cholinesterase and serum glutamic oxalacetic transaminase activity in liver diseases].
    PIETSCHMANN H
    Wien Z Inn Med; 1960 Oct; 41():409-14. PubMed ID: 13735630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.